ENVISTA HOLDINGS CORP (NVST) Stock Price, Forecast & Analysis
USA • New York Stock Exchange • NYSE:NVST • US29415F1049
NVST Key Statistics, Chart & Performance
The current stock price of NVST is 23.26 USD. In the past month the price increased by 7.24%. In the past year, price increased by 9.46%.
NVST Technical Analysis
ChartMill assigns a technical rating of 7 / 10 to NVST. When comparing the yearly performance of all stocks, NVST is one of the better performing stocks in the market, outperforming 75.01% of all stocks.
NVST Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to NVST. Both the profitability and the financial health of NVST get a neutral evaluation. Nothing too spectacular is happening here.
NVST Financial Highlights
Over the last trailing twelve months NVST reported a non-GAAP Earnings per Share(EPS) of 1.06. The EPS increased by 35.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 0.58% | ||
| ROA | 0.27% | ||
| ROE | 0.5% | ||
| Debt/Equity | 0.47 |
NVST Forecast & Estimates
21 analysts have analysed NVST and the average price target is 22.83 USD. This implies a price decrease of -1.84% is expected in the next year compared to the current price of 23.26.
For the next year, analysts expect an EPS growth of 59.27% and a revenue growth 5.56% for NVST
NVST Ownership
NVST Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 21.24 | 190.25B | ||
| ISRG | INTUITIVE SURGICAL INC | 55.62 | 176.09B | ||
| SYK | STRYKER CORP | 27.01 | 140.78B | ||
| BSX | BOSTON SCIENTIFIC CORP | 31.14 | 136.19B | ||
| BDX | BECTON DICKINSON AND CO | 14 | 57.63B | ||
| IDXX | IDEXX LABORATORIES INC | 48.94 | 51.07B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.16 | 47.96B | ||
| RMD | RESMED INC | 24.78 | 37.18B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.45 | 36.49B | ||
| DXCM | DEXCOM INC | 38.99 | 28.29B | ||
| PODD | INSULET CORP | 56.15 | 18.05B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.66 | 17.09B |
Related stock screener links
About NVST
Company Profile
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,300 full-time employees. The company went IPO on 2019-09-18. The firm's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. The company has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
Company Info
ENVISTA HOLDINGS CORP
200 S. Kraemer Blvd., Bldg. E
Brea CALIFORNIA 92821 US
CEO: Amir Aghdaei
Employees: 12300
Phone: 17148175418
ENVISTA HOLDINGS CORP / NVST FAQ
What does NVST do?
Envista Holdings Corp. engages in the manufacturing and marketing of dental products, diagnostics, treatment, and trading. The company is headquartered in Brea, California and currently employs 12,300 full-time employees. The company went IPO on 2019-09-18. The firm's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. The company has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.
What is the stock price of ENVISTA HOLDINGS CORP today?
The current stock price of NVST is 23.26 USD. The price decreased by -0.89% in the last trading session.
Does NVST stock pay dividends?
NVST does not pay a dividend.
What is the ChartMill rating of ENVISTA HOLDINGS CORP stock?
NVST has a ChartMill Technical rating of 7 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
What is the GICS sector and industry of NVST stock?
ENVISTA HOLDINGS CORP (NVST) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
Would investing in ENVISTA HOLDINGS CORP be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on NVST.
Who owns ENVISTA HOLDINGS CORP?
You can find the ownership structure of ENVISTA HOLDINGS CORP (NVST) on the Ownership tab.